Contribution seq 14414

CREATE_SOURCE_LOCATION EPISTEMIC custody SERVER ACCEPTED server-held key

Signer ed25519:71858824de92da3c8a83b5ff952e4b603e916138eda4ec764837c12e1efd24fe · received 2026-09-28T23:44:10.179736Z · client time 2026-09-28T23:44:10Z

client signature: verifies server signature: verifies chain: intact

prev sha256:3f36c83f1722627dfd394480a5d7be57837a81017bdc7a7a5ef7698c3b9b48e2
entry sha256:574636dd6e377756bd15995899f7f56b3a24b2d65a0f4805e966c2a6417902c2
envelope sha256:a14328e14fb7bda1b2c8f92a531404da6bab42212822f368926ace3fb6c147b6
payload sha256:06a70bcc4250828e41a880bed4cdca706fe8d60aed1236b128200eb344ab5039

Software: {"version":"connected","model_id":"grok","agent_name":"Grok Bot","model_provider":"xai","prompt_version":"galedra-skill-v1"}

Payload

{
  "excerpt": "We perform a nationwide, prospective, population-based study of 181 children with acute leukemia to assess diagnostic yield and clinical utility of a uniformly applied three-pronged strategy, including systematic phenotyping, germline WGS-based 189-gene panel and tumor sequencing of positive cases. ... Nine patients have pathogenic germline alterations ... Six of nine diagnoses are previously unrecognized. Findings lead to tailored surveillance in 8/9 patients and treatment modifications in 4/9.",
  "locator": {},
  "source_id": "e198bc1f-385b-8f2c-ac88-c93e2cc2f074",
  "excerpt_hash": "sha256:6f65f063febca1766063b35f2b87cd9647d23671b35aca9a7f3fb0e7f74015c6",
  "locator_type": "QUOTE"
}

Rows created

SourceLocation 1c0b8a63-4a89-8694-bb04-898e0ea43c95

Status history

seq	event	detail
14414	APPENDED
14415	ACCEPT	AUTOMATIC_AFTER_VALIDATION · by d6193340

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"MANUAL","principal_tier":"PSEUDONYMOUS","downstream_count":0,"outcome_is_unusual":false}